Carlo V. Catapano
Director
General Science
ENTRECHEM
Spain
Biography
Carlo V. Catapano is the Director of Institute of Oncology Research (IOR) and Head of the Tumor Biology and Experimental Therapeutics Program in Bellinzona, Switzerland. He received his MD from the University of Naples, Italy, and his PhD in Biochemistry from Wake Forest University (WFU) in Winston-Salem, North Carolina, USA. He trained in medical oncology at the University of Naples, in cancer pharmacology at the Mario Negri Institute for Pharmacological Research in Milan, Italy, and later in biochemistry and molecular biology at WFU. From 1993 he was a faculty at the Medical University of South Carolina (MUSC; Depts of Experimental Oncology, Biochemistry and Molecular Biology, and Medicine) and at the Hollings Cancer Center, Center for Molecular and Structural Biology, and the Laboratory of Cancer Genomic in Charleston, SC, USA. From 2003 he has been the Director of the Laboratory of Experimental Oncology of the Oncology Institute of Southern Switzerland (IOSI) and since 2010 of the IOR. Research in his group focuses on development of new therapeutics with a major emphasis on targeting transcription factors, epigenetic regulators and non-coding RNAs in cancer. At the IOR, he directs also the Tumor Biology and Experimental Therapeutics Program – an interdisciplinary basic and translational research program on prostate cancer and other epithelial tumors spanning from genomics and molecular biology to experimental therapeutics, preclinical pharmacology and early phase clinical trials.
Research Interest
General Science